Synthesis of new riminophenazines with pyrimidine and pyrazine substitution at the 2-N position

Molecules

Volumn 16, Issue 8, 2011, Pages 6985-6991

  Zhang, Gang ^a   Zhang, Hao ^a   Wang, Xiaojian ^a   Li, Chun ^a   Huang, Haihong ^a   Yin, Dali ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

N arylation; Palladium catalyst; Riminophenazine

Indexed keywords

PALLADIUM; PHENAZINE DERIVATIVE; PYRAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE; TUBERCULOSTATIC AGENT;

ARTICLE; CATALYSIS; CHEMISTRY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; METHODOLOGY; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORGANIC CHEMISTRY; SYNTHESIS; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; CATALYSIS; CHEMISTRY, ORGANIC; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MYCOBACTERIUM TUBERCULOSIS; PALLADIUM; PHENAZINES; PYRAZINES; PYRIMIDINES; TUBERCULOSIS;

EID: 80052220809     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16086985     Document Type: Article

References (13)

1. Barry, V.C.; Belton, J.G.; Conalty, M.L.; Twomey, D. Anti-tubercular activity of oxidation products of substituted o-phenylene diamines. Nature 1948, 162, 622-623.
2. Browne, S.G.; Hogerzeil, L.M. B663 in the treatment of leprosy. Preliminary report of a pilot trial. Lepr. Rev. 1962, 33, 6-10.
3. van Rensburg, C.E.; van Staden, A.M.; Anderson, R. The riminophenazine agents clofazimine and B669 inhibit the proliferation of cancer cell lines in vitro by phospholipase A2-mediated oxidative and nonoxidative mechanisms. Cancer Res. 1993, 53, 318-323. (Pubitemid 23031843)
4. Imkamp, F.M. A treatment of corticosteroid-dependent lepromatous patient in persistent erythema nodosum leprosum: A clinical evaluation of G.30320 (B663). Lepr. Rev. 1968, 39, 119-125.
5. Mackey, J.P.; Barnes, J. Clofazimine in the treatment of discoid lupus erythematosus. Brit. J. Dermatol. 1974, 91, 93-96.
6. Kaplan, B.; Trau, H.; Sofer, E.; Feinstein, A.; Schewach-Millet, M. Treatment of pyoderma gangrenosum with clofazimine. Int. J. Dermatol. 1992, 31, 591-593.
7. Yew, W.W.; Chau, C.H. New antimycobacterial agents. Monaldi Arch. Chest Dis. 1996, 51, 394-404. (Pubitemid 27062784)
8. Barry, V.C.; Belton, J.G.; O'Sullivan, J.F.; Twomey, D. The oxidation of derivatives of o-phenylenediamine. Part I. Isomeric phenazine pigments obtained by oxidation of 2-aminodiphenylamine hydrochloride. J. Chem. Soc. (Resumed) 1956, 888-893.
9. Girard, A.; Ray, A. Novel phenazine compounds and process. U.S. Patent 3,499,899, 10 March 1970.
10. Vo, G.D.; Hartwig, J.F. Palladium-catalyzed coupling of ammonia with aryl chlorides, bromides, iodides, and sulfonates: A general method for the preparation of primary arylamines. J. Am. Chem. Soc. 2009, 131, 11049-11061.
11. Grasa, G.A.; Viciu, M.S.; Huang, J.; Nolan, S.P. Amination reactions of aryl halides with nitrogen-containing reagents mediated by Palladium/Imidazolium salt systems. J. Org. Chem. 2001, 66, 7729-7737. (Pubitemid 33063968)
12. Guram, A.; Rennels, R.; Buchwald, S. A simple catalytic method for the conversion of aryl bromides to arylamines. Angew. Chem. Int. Ed. Engl. 1995, 34, 1348-1350.
13. Tietze, M.; Iglesias, A.; Merisor, E.; Conrad, J.; Klaiber, I.; Beifuss, U. Efficient methods for the synthesis of 2-hydroxyphenazine based on the Pd-catalyzed N-arylation of aryl bromides. Org. Lett. 2005, 7, 1549-1552. (Pubitemid 40585928)